Xenon Pharmaceuticals Inc
XP0
Company Profile
Business description
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Contact
200-3650 Gilmore Way
BurnabyBCV5G 4W8
CANT: +1 604 484-3300
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
327
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,774.80 | 86.80 | 1.00% |
| CAC 40 | 7,615.99 | 78.42 | 1.04% |
| DAX 40 | 23,644.21 | 375.20 | 1.61% |
| Dow JONES (US) | 43,011.75 | 429.97 | 1.01% |
| FTSE 100 | 8,758.99 | 0.95 | 0.01% |
| HKSE | 24,177.07 | 487.94 | 2.06% |
| NASDAQ | 19,905.30 | 274.33 | 1.40% |
| Nikkei 225 | 38,790.56 | 436.47 | 1.14% |
| NZX 50 Index | 12,467.48 | 65.17 | -0.52% |
| S&P 500 | 6,084.29 | 59.12 | 0.98% |
| S&P/ASX 200 | 8,555.50 | 80.60 | 0.95% |
| SSE Composite Index | 3,420.57 | 38.98 | 1.15% |